These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 22824646)

  • 21. A review of content-based image retrieval systems in medical applications-clinical benefits and future directions.
    Müller H; Michoux N; Bandon D; Geissbuhler A
    Int J Med Inform; 2004 Feb; 73(1):1-23. PubMed ID: 15036075
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Posterior uveal pseudomelanoma. Clinical differential diagnosis at the referral hospital].
    Valverde Almohalla S; Martín Rodrigo J; Alvarez Viersou H; Encinas Martín JL
    Arch Soc Esp Oftalmol; 2000 Aug; 75(8):529-34. PubMed ID: 11151214
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Treatment considerations for primary uveal melanoma with choroidal metastasis to the fellow eye.
    Bourla DH; Young TA
    Semin Ophthalmol; 2007; 22(3):175-7. PubMed ID: 17763240
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Impact of COVID-19 on a rare disease (uveal melanoma) in a national reference unit of intraocular tumors in Spain.
    Bermudez-Castellanos I; Saornil Álvarez MA; Almaraz Gómez A; Villoria-Diaz S; García Álvarez C
    Arch Soc Esp Oftalmol (Engl Ed); 2023 May; 98(5):254-258. PubMed ID: 37075839
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Locoregional management of hepatic metastasis from primary uveal melanoma.
    Sato T
    Semin Oncol; 2010 Apr; 37(2):127-38. PubMed ID: 20494705
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Update on the management of posterior uveal melanoma.
    Zhao DY; Shields CL; Shields JA; Gunduz K
    J Ophthalmic Nurs Technol; 1998; 17(2):66-71. PubMed ID: 9677975
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cytogenetics of uveal melanoma: a 7-year clinical experience.
    Damato B; Duke C; Coupland SE; Hiscott P; Smith PA; Campbell I; Douglas A; Howard P
    Ophthalmology; 2007 Oct; 114(10):1925-31. PubMed ID: 17719643
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Metastatic melanoma in the eye and orbit.
    Zografos L; Ducrey N; Beati D; Schalenbourg A; Spahn B; Balmer A; Othenin-Girard CB; Chamot L; Egger E
    Ophthalmology; 2003 Nov; 110(11):2245-56. PubMed ID: 14597536
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [What else can we do for uveal melanoma].
    Li B; Xu XL
    Zhonghua Yan Ke Za Zhi; 2009 Apr; 45(4):289-92. PubMed ID: 19575957
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Identification of circulating malignant cells and its correlation with prognostic factors and treatment in uveal melanoma. A prospective longitudinal study.
    Callejo SA; Antecka E; Blanco PL; Edelstein C; Burnier MN
    Eye (Lond); 2007 Jun; 21(6):752-9. PubMed ID: 16575415
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Screening for uveal melanoma metastasis. Literature review.
    Missotten GS; Keunen JE
    Bull Soc Belge Ophtalmol; 2004; (294):13-22. PubMed ID: 15682915
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Metastatic uveal melanoma.
    Singh AD; Borden EC
    Ophthalmol Clin North Am; 2005 Mar; 18(1):143-50, ix. PubMed ID: 15763199
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Melanocortin 1 receptor is expressed by uveal malignant melanoma and can be considered a new target for diagnosis and immunotherapy.
    López MN; Pereda C; Ramírez M; Mendoza-Naranjo A; Serrano A; Ferreira A; Poblete R; Kalergis AM; Kiessling R; Salazar-Onfray F
    Invest Ophthalmol Vis Sci; 2007 Mar; 48(3):1219-27. PubMed ID: 17325166
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evolving systemic targeted therapy strategies in uveal melanoma and implications for ophthalmic management: a review.
    Goh AY; Layton CJ
    Clin Exp Ophthalmol; 2016 Aug; 44(6):509-19. PubMed ID: 26601795
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [A computerized database for managing otorhinolaryngologic oncology patients].
    Mira E; Lanza L; Castelli A; Benazzo M; Tinelli C
    Acta Otorhinolaryngol Ital; 1998 Jun; 18(3):155-63. PubMed ID: 9926449
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Applications and advantages of a multimedia system for autopsies ].
    Gualco M; Benzi D; Fulcheri E
    Pathologica; 2001 Oct; 93(5):517-30. PubMed ID: 11725353
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Methodological aspects and problems of a hospital-based case-control study on uveal melanoma. A case study.
    Stang A; Ahrens W; Anastassiou G; Bornfeld N; Jöckel KH
    Stud Health Technol Inform; 2000; 77():111-3. PubMed ID: 11187493
    [No Abstract]   [Full Text] [Related]  

  • 38. Posterior uveal melanoma treated with I-125 brachytherapy or primary enucleation.
    Krohn J; Monge OR; Skorpen TN; Mørk SJ; Dahl O
    Eye (Lond); 2008 Nov; 22(11):1398-403. PubMed ID: 17585309
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Selected prognostic factors of malignant uveal melanoma].
    Svetlosáková Z; Krásnik V; Gergisáková H; Babál P; Kusenda P
    Cesk Slov Oftalmol; 2012 Feb; 68(1):38-42. PubMed ID: 22679696
    [TBL] [Abstract][Full Text] [Related]  

  • 40. CNS metastasis from malignant uveal melanoma: a clinical and histopathological characterisation.
    Holfort SK; Lindegaard J; Isager P; Prause JU; Heegaard S
    Br J Ophthalmol; 2009 May; 93(5):641-4. PubMed ID: 19091854
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.